,HIV-B

Flavio Matassoli1, Alberto Cagigi1, Chen-Hsiang Shen1

  • 1Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Cell reports
|November 29, 2023
PubMed
概括

与美国人口相比,撒哈拉以南非洲人群显示了更高或相当的天真B细胞识别工程HIV外部域 (eOD-GT8) 的频率. 这表明eOD-GT8疫苗可能有效地扩大非洲的保护性B细胞.